Enhanced Post-Receptor Insulin Effects in Women Following Dehydroepiandrosterone Infusion

Journal of the Society for Gynecologic Investigation

Volumn 1, Issue 1, 1994, Pages 74-78

  Schriock, Eldon D ^a   Buffington, Cynthia K ^a   Givens, James R ^a   Buster, John E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

DHEA; insulin; polycystic ovary syndrome

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; INSULIN; INSULIN RECEPTOR; PHYTOHEMAGGLUTININ; PRASTERONE; PYRUVATE DEHYDROGENASE COMPLEX;

ADOLESCENT; ADULT; ARTICLE; BASAL METABOLIC RATE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ADOLESCENT; ADULT; BASAL METABOLISM; C-PEPTIDE; DEHYDROEPIANDROSTERONE; ENZYME ACTIVATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; OBESITY; PHYTOHEMAGGLUTININS; POLYCYSTIC OVARY SYNDROME; PYRUVATE DEHYDROGENASE COMPLEX; RECEPTOR, INSULIN; T-LYMPHOCYTES;

EID: 0028366639     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1177/107155769400100115     Document Type: Article

References (24)

1. Schriock ED, Buffington CK, Hubert GD, et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988; 66: 1329-31.
2. Buffington CK, Givens JR, Kitabchi AE Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity: In vivo and in vitro studies of hyperandrogenic females. Diabetes 1991; 40: 693-700.
3. Burghen GA, Givens JR, Kitabchi AE Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50: 113-6.
4. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
5. Buffington CK, El-Sheikh T., Kitabchi AE, Matteri RT Phytohemagglutinin (PHA)-activated human T-lymphocytes: Concomitant appearance of insulin binding, degradation, and insulin mediated activation of pyruvate dehydrogenase. Biochem Biophy Res Commun 1986; 134: 412-9.
6. Krug U., Krug F., Cuatrecasas P. Emergence of insulin receptors on human lymphocytes during in vitro transformation. Proc Natl Acad Sci USA 1972;69: 2604-8.
7. Nestler JE, Barlascini CO, Clore JN, Blackard WG Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66: 57-61.
8. Usiskin KS, Butterworth S., Clore JN, et al. Lack of effect of dehydroepiandrosterone in obese men. Int J Obes 1990; 14: 457-463.
9. Welle S., Jozefowicz R., Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab 1990; 71: 1259-64.
10. Mortola JF, Yen SS The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990; 71: 696-704.
11. Ercolani L., Lin HL, Ginsberg BH Insulin-induced densensitization at the receptor and postreceptor level in mitogen-activated human T-lymphocytes. Diabetes 1985; 34: 931-7.
12. Helderman JH, Reynolds TC, Strom TB The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol 1978;8: 589-595.
13. Helderman JH The role of insulin in intermediary metabolism of the activated thymic derived lymphocytes. J Clin Invest 1981; 67: 1636-42.
14. Buffington CK, Givens JR, Kitabchi AE Sensitivity of pyruvate dehydrogenase to insulin in activated T-lymphocytes. Diabetes 1990; 39: 361-8.
15. Curto M., Piccinni M., Bruno R., Mostert M., Rinaudo MT Insulin modulation of pyruvate dehydrogenase in human circulating lymphocytes. Int J Biochem 1988; 20: 1211-7.
16. Kerr DS, Berry SA, Lusk MN, Lap H., Patel MS A deficiency of both subunits of pyruvate dehydrogenase which is not expressed in fibroblasts. Pediatr Res 1988;24: 95-100.
17. Rinaudo MT, Curto M., Bruno C., et al. The behavior of pyruvate dehydrogenase in circulating lymphocytes from diabetic children. Diabetologia 1989; 32: 245-8.
18. Helderman JH, Pietri AO, Raskin P. In vitro control of T-lymphocyte insulin receptors by in vivo modulation of insulin. Diabetes 1983; 32: 712-7.
19. Kitabchi AE, Buffington CK, Givens JR, Inouye H. The role of testosterone and dehydroepiandrosterone on insulin resistance and sensitivity in hyperandrogenic females: Use of activated T-lymphocytes as an in vitro study model and its correlation to in vivo studies. In: Dunaif A., Givens Jr, Haseltine FP, Merian GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications, 1991: 289-305.
20. Holmang A., Svedberg J., Jennische E., Bjorntorp P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J Physiol 1990; 259: E555-E560.
21. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes. Inhibition by estrogens and potentiation by androgens. Diabetes 1982; 31: 724-9.
22. Coleman DL, Leiter EH, Applezweig N. Therapeutic effects of dehydroepiandrosterone metabolites in diabetic mutant mice. Endocrinology 1984; 115: 239-243.
23. Leiter EH, Beamer WG, Coleman DL, Longscope C. Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: Relationship to antihyperglycemic effects. Metabolism 1987; 36: 863-9.
24. Pourmatobbed G., Buffington C., Williams-Cleaves B., Stentz F., Kitabchi AE Dehydroepiandrosterone administration increases insulin sensitivity. Clin Res 1991; 39: 836A.